Tobacco Regulation
Page 1 • 2 itemsNavigate global tobacco regulation shifts impacting pharma. Stay ahead of policy changes, market access, and compliance for strategic B2B advantage.
Philip Morris International Receives FDA Reauthorization for IQOS Modified Risk Tobacco Product
FDA renews Philip Morris International's modified risk tobacco product authorization for IQOS devices and HEETS consumables, allowing continued reduced-exposure claims.
FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product for Continued U.S. Marketing
FDA renews Philip Morris International's IQOS modified risk tobacco product authorization, allowing continued reduced-exposure claims for HEETS variants.